Results for &quot;&quot;Retinoblastoma-Like Protein p130&quot;&quot;[mesh_terms]

pRb2/p130: a new candidate for retinoblastoma tumor formation.

G De Falco, A Giordano

Oncogene 2006;25(38):5333-40

The RB2/p130 gene: the latest weapon in the war against lung cancer?

P P Claudio, A Giordano, M Caputi

Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):754-64

pRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumor grade.

Francesca Sanseverino, Rosa Santopietro, Michela Torricelli, Giuseppina D'Andrilli, Giuseppe Russo, Gabriele Cevenini, Alessandro Bovicelli, Lorenzo Leoncini, Giovanni Scambia, Felice Petraglia, Pier Paolo Claudio, Antonio Giordano

Cancer biology & therapy 2006;5(1):84-8

The switch from pRb/p105 to Rb2/p130 in DNA damage and cellular senescence.

Heike Helmbold, Umberto Galderisi, Wolfgang Bohn

Journal of cellular physiology 2012;227(2):508-13

MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes.

Minmin Shi, Youwei Zhu, Jiangning Gu, Ying Li, Chenghong Peng, Xuelong Wang, Gang Wei, Ouyang Ge, Di Wang, Bosen Zhang, Jian Wu, Yiming Zhong, Baiyong Shen, Hao Chen

Cancer letters 2017;412():59-68

Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid.

E Purev, K J Soprano, D R Soprano, S Vuocolo

Oncogene 2006;25(38):5315-25

PP1 and PP2A phosphatases--cooperating partners in modulating retinoblastoma protein activation.

Victoria Kolupaeva, Veerle Janssens

The FEBS journal 2013;280(2):627-43

Silencing of RB1 and RB2/P130 during adipogenesis of bone marrow stromal cells results in dysregulated differentiation.

Stefania Capasso, Nicola Alessio, Giovanni Di Bernardo, Marilena Cipollaro, Mariarosa Ab Melone, Gianfranco Peluso, Antonio Giordano, Umberto Galderisi

Cell cycle (Georgetown, Tex.) 2015;13(3):482-90

pRb2/p130 protein in relation to clinicopathological and biological variables in rectal cancers with a clinical trial of preoperative radiotherapy.

Satish Babu Moparthi, Viveka Bergman, Gunnar Adell, Sten Thorstensson, Xiao-Feng Sun

International journal of colorectal disease 2009;24(11):1303-10

The DREAM complex in antitumor activity of imatinib mesylate in gastrointestinal stromal tumors.

James A DeCaprio, Anette Duensing

Current opinion in oncology 2015;26(4):415-21

Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence.

H Helmbold, N Kömm, W Deppert, W Bohn

Oncogene 2009;28(39):3456-67

Geminiviruses and the plant cell cycle.

C Gutierrez

Plant molecular biology 2000;43(5-6):763-72

The retinoblastoma family member pRb2/p130 is an independent predictor of survival in human soft tissue sarcomas.

Valeria Masciullo, Ester Berardengo, Antonella Boglione, Alessandro Sgambato, Amelia Bernardi, Marco Forni, Alessandra Linari, Letizia Cito, Giovanni Scambia, Alessandro Comandone, Antonio Giordano

Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(15):4775-9

Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells.

Nicola Alessio, Wolfgang Bohn, Verena Rauchberger, Flavio Rizzolio, Marilena Cipollaro, Michael Rosemann, Martin Irmler, Johannes Beckers, Antonio Giordano, Umberto Galderisi

Cellular and molecular life sciences : CMLS 2013;70(9):1637-51